An efficient, palladium-catalyzed, enantioselective synthesis of (2R)-3-butene-1,2-diol and its use in highly selective Heck reactions
- Dowpharma, Chirotech Technology Ltd., A Subsidiary of the Dow Chemical Company, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom
-
Edited by Barry M. Trost, Stanford University, Stanford, CA, and approved December 12, 2003 (received for review October 30, 2003)
Abstract
A robust and scalable procedure for the palladium-catalyzed dynamic kinetic asymmetric transformation of 3,4-epoxy-1-butene into (2R)-3-butene-1,2-diol with water as the cosolvent is reported. Examination of the effects of solvent and temperature led to the identification of conditions that permitted use of 0.025 mol % catalyst, providing (2R)-3-butene-1,2-diol in 84% isolated yield and 85% enantiomeric excess. Subsequent Heck reactions with a diverse range of coupling partners are described and the influence of their electronic nature on maintaining the enantiopurity of the diol is discussed.
Footnotes
-
↵ † To whom correspondence should be addressed. E-mail: gmeek{at}dow.com.
-
↵ * Present address: H33-S-018, GlaxoSmithKline, New Frontiers Science Park (North), Third Avenue, Harlow, Essex CM19 5AW, United Kingdom.
-
This paper was submitted directly (Track II) to the PNAS office.
-
Abbreviations: Pd2dba3·CHCl3, tris(dibenzylideneacetone)dipalladium(0)·chloroform adduct; THF, tetrahydrofuran; MTBE, methyl tert-butyl ether; P(o-tol)3, tri-o-tolylphosphine; ee, enantiomeric excess.
- Copyright © 2004, The National Academy of Sciences





